A real-world experience with a thin-strut bioresorbable vascular scaffold system: a single-centre study.

ABSTRACT:

Background

Despite the significant advancements in interventional cardiology, there is a need for new, metal-free bioresorbable stent systems that preserve the vasomotor function of the treated vessel and decrease the risk of restenosis associated with metal stents and the risk of thrombosis associated with first-generation bioresorbable scaffolds.

Aims

The aim of this study was to assess the safety and efficacy of the MeRes100 bioresorbable scaffold in complex de novo and in-stent restenotic coronary lesions.

Methods

We conducted a retrospective single-centre study that included 86 patients with coronary artery disease who had been implanted with a next-generation MeRes100 sirolimus-eluting bioresorbable vascular scaffold system and followed up to 12 months af

SUBMITTER: Verma PK 

PROVIDER: S-EPMC11905108 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature